Manish S Bhandare - JoVE Visualize

Showing results (41-50 of 50) with videos related to

Pageof 5

Sort By:

You have reached the last page of results.This site can display upto 50 results.

Annals of Surgical Oncology|November 25, 2025

The Role of HIPEC in Isolated Cytology-Positive Gastric Cancer: Nodal Metastasis Dominates Prognosis, HIPEC Remains UnprovenKunal Nandy, Amir Parray, Akshay Dhaiya, et al.

Surgery|December 19, 2021

Neoadjuvant therapy in borderline resectable pancreatic cancer: Outcomes in the era of changing practices and evolving evidenceVikram A Chaudhari, Abhishek Mitra, Vikas Gupta, et al.

Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|June 22, 2025

Intraoperative revision of a positive proximal resection margin is associated with improved survival in patients undergoing resection for gastroesophageal junction and proximal third gastric adenocarcinomaKaival Gundavda, Narayanan Rajavelu, Amit Chopde, et al.

Annals of Surgery|June 28, 2024

CA 19-9 Surveillance Detects Recurrences Early and Contributes to Improvement in Survival in Resected Ampullary Cancers: Analysis of 572 casesManish S Bhandare, Gurudutt P Varty, Ravi Chandra Reddy Obili, et al.

BJS Open|August 1, 2024

Evolution and improved outcomes in the era of multimodality treatment for extended pancreatectomyVikram A Chaudhari, Aditya R Kunte, Amit N Chopde, et al.

Journal of Gastrointestinal Cancer|June 14, 2024

Factors Predicting Prognosis in Metastatic Grade 1 Gastro-entero-pancreatic Neuroendocrine TumorsSaneya A Pandrowala, Deeksha Kapoor, Aditya Kunte, et al.

Surgery|September 24, 2019

Surgery for cystic tumors of pancreas: Report of high-volume, multicenter Indian experience over a decadeVikram A Chaudhari, Rebala Pradeep, H Ramesh, et al.

Annals of Surgery|June 11, 2020

Outcomes of Elective Major Cancer Surgery During COVID 19 at Tata Memorial Centre: Implications for Cancer Care PolicyShailesh V Shrikhande, Prathmesh S Pai, Manish S Bhandare, et al.

BMC Cancer|October 29, 2025

PReCedeNT trial: Phase III randomized-controlled trial of Lutetium - 177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) plus Chemotherapy versus PRRT alone in FDG-avid, Well-differentiated Gastroenteropancreatic neuroendocrine tumors (GEP-NETs)Ameya D Puranik, Indraja D Dev, Sushil Yadav, et al.

Annals of Surgical Oncology|July 5, 2025

Real-World Evidence of Porto-Mesenteric Vein Resections with Pancreatectomy and the Development of Predictive Clinical Nomograms for Postoperative Outcomes-An Analysis of 389 Cases: The "Porto-Mesenteric Vein Resection-Indian MulticentrE" (PRIME) StudyDeeksha Kapoor, Manish S Bhandare, Agam Sharma, et al.

Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:

Pageof 5

You have reached the last page of results.This site can display upto 50 results.

Annals of Surgical Oncology|November 25, 2025

The Role of HIPEC in Isolated Cytology-Positive Gastric Cancer: Nodal Metastasis Dominates Prognosis, HIPEC Remains UnprovenKunal Nandy, Amir Parray, Akshay Dhaiya, et al.

Surgery|December 19, 2021

Neoadjuvant therapy in borderline resectable pancreatic cancer: Outcomes in the era of changing practices and evolving evidenceVikram A Chaudhari, Abhishek Mitra, Vikas Gupta, et al.

Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|June 22, 2025

Intraoperative revision of a positive proximal resection margin is associated with improved survival in patients undergoing resection for gastroesophageal junction and proximal third gastric adenocarcinomaKaival Gundavda, Narayanan Rajavelu, Amit Chopde, et al.

Annals of Surgery|June 28, 2024

CA 19-9 Surveillance Detects Recurrences Early and Contributes to Improvement in Survival in Resected Ampullary Cancers: Analysis of 572 casesManish S Bhandare, Gurudutt P Varty, Ravi Chandra Reddy Obili, et al.

BJS Open|August 1, 2024

Evolution and improved outcomes in the era of multimodality treatment for extended pancreatectomyVikram A Chaudhari, Aditya R Kunte, Amit N Chopde, et al.

Journal of Gastrointestinal Cancer|June 14, 2024

Factors Predicting Prognosis in Metastatic Grade 1 Gastro-entero-pancreatic Neuroendocrine TumorsSaneya A Pandrowala, Deeksha Kapoor, Aditya Kunte, et al.

Surgery|September 24, 2019

Surgery for cystic tumors of pancreas: Report of high-volume, multicenter Indian experience over a decadeVikram A Chaudhari, Rebala Pradeep, H Ramesh, et al.

Annals of Surgery|June 11, 2020

Outcomes of Elective Major Cancer Surgery During COVID 19 at Tata Memorial Centre: Implications for Cancer Care PolicyShailesh V Shrikhande, Prathmesh S Pai, Manish S Bhandare, et al.

BMC Cancer|October 29, 2025

PReCedeNT trial: Phase III randomized-controlled trial of Lutetium - 177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) plus Chemotherapy versus PRRT alone in FDG-avid, Well-differentiated Gastroenteropancreatic neuroendocrine tumors (GEP-NETs)Ameya D Puranik, Indraja D Dev, Sushil Yadav, et al.

Annals of Surgical Oncology|July 5, 2025

Real-World Evidence of Porto-Mesenteric Vein Resections with Pancreatectomy and the Development of Predictive Clinical Nomograms for Postoperative Outcomes-An Analysis of 389 Cases: The "Porto-Mesenteric Vein Resection-Indian MulticentrE" (PRIME) StudyDeeksha Kapoor, Manish S Bhandare, Agam Sharma, et al.

Pageof 5